Loading...
Systemic Therapy for Advanced Soft Tissue Sarcomas
Soft tissue sarcomas (STS) are a rare, heterogeneous group of solid tumors in need of improved therapeutic options. First-line chemotherapy is considered the current standard of care for patients with advanced, symptomatic STS, but the median survival is only 8 to 12 months. Efforts to increase resp...
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Wiley Subscription Services, Inc., A Wiley Company
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3412982/ https://ncbi.nlm.nih.gov/pubmed/21837668 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.26415 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|